Top 5 Most Read RNS's on Vox Markets for Wednesday 12th October 2022

06:59, 12th October 2022

If you find this podcast useful please give it a rating and review on iTunes by clicking here

Top 5 Most Read RNS's on Vox Markets for Wednesday 12th October 2022

 

5.   - COPL Receives Gas Flaring Approval

Announce the Wyoming Oil and Gas Conservation Commission granted the application by Company's affiliate Southwestern Production to temporarily flare additional gas volumes at its operated 85% WI Barron Flats Shannon Unit.

4.   - Issue of Equity

Dukemount has issued 74,575,000 ordinary shares to settle a 9.5% extension fee of £74,575 to its existing Noteholders.

3.    - Clinical trial update

Announce the start of recruitment for the pharmacokinetic/pharmacodynamic trial in healthy volunteers (HV) and the decision to commence an Investigator Sponsored clinical study (ISS) for the glioblastoma programme.

2.   - Revised Spud Date and Process Capacity Milestone

Following a scheduled maintenance shutdown last week, hourly throughput rates through the process plant (i.e. sales gas) now exceeds our October target production rate of 6 million standard cubic feet per day with well pressures holding in the high forties.

1.   - Response to Market Speculation

The Company and its Broker recently began the process of seeking to raise equity, not only to repay and retire the Convertible Loan Facility but also to fund sufficiently the Company's working capital requirements to enable the Company to reach profitability and cash generation during 2023. However, particularly given the impact of the above-mentioned speculation on the share price, and although the institutional equity roadshow is progressing well with positive feedback, there can be no guarantees that sufficient equity funds can be raised, nor the terms thereof.

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

    Watchlist